Skip to main content

HomeResearchCompareDalargin vs P21

Peptide Comparison

Dalargin vs P21

Both are Neuro & Cognitive peptides.

Dalargin

Leu-enkephalin-Arg

RecoveryNot EvaluatedResearch Only

No providers listed yet

Full Dalargin profile →
vs

P21

CNTF fragment

CognitiveNot EvaluatedResearch Only

Half-life: Unknown

5 providers listed

Full P21 profile →
Bottom line

P21 is carried by more providers on PeptideBase (5 vs 0); otherwise the two are closely matched on the measures we track.

Quick Verdict

Dalargin

P21

Which One Should You Choose?
Your goalBetter option
Stronger clinical evidenceP21
More provider options (0 vs 5)P21

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Dalargin
P21
Mechanism Family
Neuro & Cognitive
Neuro & Cognitive
Half-life
Unknown
FDA Status
not evaluated
not evaluated
Admin Routes
subcutaneous, intravenous
subcutaneous, intranasal
Availability
Research Only
Research Only
Providers
None listed
5 listed
Avail. Notes
CNTF-derived pentapeptide fragment studied for cognitive enhancement in animal models. No FDA approval, no NDA or IND. Not on any FDA list. Very limited human research. Research compound.
Research Evidence

Dalargin

Animal · 1 key study · dated evidence base — most recent 2009

P21

Animal · 2 key studies · most recent 2017
Research Citations

About Dalargin

Binds delta and mu opioid receptors with peripheral preference due to limited CNS penetration. Reduces gastric acid secretion, promotes mucosal blood flow, and inhibits ulcer formation via prostaglandin-mediated pathways.

Research Areas
gastroprotectionGI repairanti-ulcerpain modulation

About P21

Derived from CNTF; increases BDNF expression and promotes hippocampal neurogenesis; modulates PI3K/Akt pathway

Research Areas
neurogenesisBDNF upregulationmemory enhancementneuroprotection
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Dalargin

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

P21

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.